heltzen press release investor press clippings Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything' May 16, 2025 9:09:00 AM
investor press clippings video Slack Capital interview: Tyler Korman, VP of Research May 15, 2025 4:24:00 PM
heltzen investor press clippings video Slack Capital: EXOZ investment report and CEO interview May 13, 2025 5:30:00 PM
investor press clippings video science Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman Apr 15, 2025 10:09:35 AM
investor press clippings World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer Apr 3, 2025 11:45:00 AM
press clippings science Chemical Engineering: Enzyme engineering breaks out of the cell Apr 1, 2025 5:42:25 PM
investor press clippings video Fox Business: Interview with Chief Market Strategist, Lou Basenese Mar 17, 2025 7:00:00 AM
heltzen investor press clippings video Fox Business: Interview with CEO Michael Heltzen Mar 3, 2025 11:00:00 AM
press clippings GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes Feb 15, 2025 5:32:31 AM
.png?width=1024&height=1024&name=_ExoZymes%20-%20Commercial%20(1).png)
.png?width=1024&height=1024&name=ExoZymes%20-%20Science%20(1).png)
.png?width=1024&height=1024&name=ExoZymes%20-%20Introduction%20(1).png)
